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Abstract Using a yeast two-hybrid assay we detected an
interaction between the N-terminal region of histone H4 (amino
acids 1^59) and a fragment of the bromodomain factor 1 protein
(Bdf1p) (amino acids 304^571) that includes one of the two
bromodomains of this protein. No interaction was observed using
fragments of histone H4 sequence smaller than the first 59 amino
acids. Recombinant Bdf1p (rBdf1p) demonstrates binding
affinity for histones H4 and H3 but not H2A and H2B in vitro.
Moreover, rBdf1p is able to bind histones H3 and H4 having
different degrees of acetylation. Finally, we have not detected
histone acetyltransferase activity associated with Bdf1p. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Activation of genes transcribed by RNA polymerase II re-
quires the prior assembly of general transcription factors that
form the pre-initiation complex. Recruitment of this complex
is normally associated with a cascade of interactions between
these general factors, DNA elements, and gene-speci¢c trans-
acting factors (i.e. transcriptional activators, mediators, and
coactivators). Throughout the process of transcription initia-
tion and subsequent activation, the chromatin at or near the
promoter region is often modi¢ed or even disassembled (re-
viewed in [1,2]). Two main types of enzymatic activities can
accomplish remodelling of chromatin structure: histone ace-
tyltransferases (HATs) [3] and a class of ATPases able to alter
nucleosome structure [4]. The reversible acetylation of lysines
in N-terminal tails of the core histones has traditionally been
correlated to the transcriptional activity of chromatin (re-
viewed in [1^3,5^7]). One model postulates that histone ace-
tylation unfolds chromatin, thus resulting in a more accessible
DNA interface. There are several lines of evidence implicating
histones, and their modi¢cations, in a more direct role for the
activation of class-II genes. Thus, it has been proposed that
transcription factors can be targeted to nucleosome-bound
regions of DNA when the N-terminal tails of histones are
acetylated in speci¢c sites [3,8,9]. Furthermore, an increasing
number of proteins related to transcriptional regulation have
been shown to have HAT activity. In yeast there are seven
di¡erent HAT activities described to date, six of them with
physical and/or functional connections to transcriptional reg-
ulation: (1) the transcriptional adaptor Gcn5p [10] ; (2)
TafII145, a component of the basal transcription factor
TFIID [11]; (3) Elp3p, a stimulator of elongation of RNA
polymerase II [12]; (4) Esa1p, a protein required for cell cycle
progression [13] ; (5) Sas3p, a silencing-related protein [14]; (6)
Nut1p, a subunit of mediator [15]. The seventh yeast protein
with HAT activity is Hat1p, an enzyme originally found in the
cytoplasm [16] but which also has been detected in the nucleus
[17] and that has been recently implicated in telomeric silenc-
ing [18]. Histone N-termini can also be the target of non-HAT
proteins such as Sir3p, Sir4p and Tup1/Ssn6, which act to
repress gene expression in yeast [19]. Together, these data
suggest that histones, and N-terminal histone modi¢cations,
may be speci¢cally recognised by regulatory proteins.
Here we present the results obtained from a yeast two-hy-
brid screen designed for the purpose of identifying such pro-
teins. We employed yeast genomic libraries in combination
with a bait plasmid expressing a fragment of histone H4 (ami-
no acids 1^59). Our results demonstrate that a portion of the
bromodomain factor 1 protein (Bdf1p) interacts with this N-
terminal fragment of histone H4. Furthermore, the region of
Bdf1p shown to interact with H4 in vivo includes one of its
two bromodomains. Additional in vitro analysis was also used
to further characterise the interaction between Bdf1p and the
core histones.
2. Materials and methods
2.1. Two-hybrid analysis
The yeast strain PJ69-4A (MATa, trp1-901, leu2-3,112, ura3-52,
his3-200, gal4v, gal80v, GAL2-ADE2, LYS2: :GAL1-HIS3, met2: :
GAL7-lacZ), vector plasmids (pGBD-C1, pGBD-C2 and pGBD-C3)
and libraries (Y2HL-C1, Y2HL-C2 and Y2HL-C3) employed in this
study were kindly supplied by Dr P. James and used as described [20].
To construct the bait plasmids, DNA fragments encoding amino
acids 1^22, 1^37, 1^59 and 1^102 (the whole protein) of histone H4
were ampli¢ed from plasmid pUK421 (obtained from Dr M. Grun-
stein) using the sense primer 5PH4 (5P-CAATAAAGAATTCTCCGG-
TAGAGG-3P) and, respectively, the antisense primers 3PH4-22 (5P-A-
TGGGATCCTATAGAATCTTTCTGTGACGCTT-3P) ; 3PH4-37 (5P-
TAGATCTCTGATAGCTGGCTTAG-3P) ; 3PH4-59 (5P-GGATTC-
CAAGATCTATTTCAAGAC-3P) and 3PH4-102 (5P-TTAACCATC-
GATTGTTTAACCACC-3P). The PCR products were cleaved and
cloned into the appropriate digested vectors: fragment 1^22 into the
EcoRI- and BamHI-digested pGBD-C3 vector; the 1^37 into the
pGBD-C3 digested with EcoRI and BglII; the 1^59 into the EcoRI-
and BglII-digested pGBD-C2 vector and the 1^102 into the EcoRI-
and ClaI-digested pGBD-C1 vector. The resulting plasmids: pGBD-
H4(1^22), pGBD-H4(1^37), pGBD-H4(1^59) and pGBD-H4(1^102),
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expected to contain in-frame fusions of each of the fragments of H4
with the DNA-binding domain (DBD) of Gal4, were con¢rmed by
DNA sequencing.
The construct pGBD-H4(1^59) was used as bait plasmid in the
screen of the yeast genomic libraries. The yeast reporter strain PJ69-
4A was transformed with this bait plasmid by the LiAc method, and
transformations of the library were made following the high e⁄ciency
method of Gietz and Schiestl [21] scaled up 10-fold. The two-hybrid
transformants were plated on synthetic complete (SC) media lacking
the appropriate amino acids. Interactions between proteins fused to
bait and prey plasmids were expected to result in the activation of
HIS3, ADE2 and lacZ transcription. The positive clones, that arise on
adenine and histidine omission plates, were screened by liquid L-ga-
lactosidase assays. In duplicate, approximately 80U106 cells were
harvested and lysed by incubation at 30‡C during 20 min with Zymo-
lyase. Crude protein extracts, obtained after centrifugation at 12 000
rpm for 5 min, were assayed to measure L-galactosidase activity using
o-nitrophenyl-L-D-galactopyranoside as substrate. The total proteins
in the crude extracts were quanti¢ed by the method of Bradford [22].
One unit of L-galactosidase activity is de¢ned as A420U103/min. Plas-
mid DNA was puri¢ed from yeast cells containing L-galactosidase
activity and used to transform DH5K Escherichia coli cells by electro-
poration. DNA was analysed by agarose gel electrophoresis and
pGAD plasmids were identi¢ed by their electrophoretical mobility.
The presence of an open reading frame (ORF) fused in-frame to the
Gal4 activation domain (AD) was con¢rmed by DNA sequencing
using the forward primer pGAD5P (5P-GGAATCACTACAGG-
GATG-3P) and the reverse primer pGAD3P (5P-GGTGCACGATG-
CACAGTTGA-3P). The ORF sequences were identi¢ed on a data-
base.
2.2. Preparation of 6UHis-tagged Bdf1p
The complete ORF encoding the Bdf1p was ampli¢ed by PCR
using yeast genomic DNA as template and the 5P-GTTAGGAGCTC-
GACCGATATCACACCCGTACAGAACGATGTG-3P and 5P-GT-
CCTCGAATTCTCACTCTTCTTCACTTTCGCTGCTAACATC-3P
sense and antisense primers, respectively. The product was digested
with SacI and EcoRI and cloned into the cleaved pRSET T7 B ex-
pression vector (Invitrogen) and con¢rmed by sequencing. This con-
struct was used to transform the E. coli strain BL21(DE3)pLysS. For
expression of full-length 6UHis-tagged Bdf1p, the transformed cells
were grown in LB medium containing ampicillin (100 Wg/ml) and
cloramphenicol (25 Wg/ml) until OD600 of 0.7, induced with IPTG at
1 mM and incubated for 4 h. Cells were harvested, washed once with
disruption bu¡er (50 mM sodium phosphate pH 8.0, 300 mM NaCl,
20 mM imidazole, 0.05% Tween-20, 5 mM L-mercaptoethanol, 1 mM
PMSF and a cocktail of protease inhibitors, Complete tablets from
Roche) and resuspended in 20 ml of this bu¡er. Cells were disrupted
by sonication. The cell extract was clari¢ed by centrifugation and the
supernatant was mixed with 50% Ni2-nitrilotriacetic (NTA) slurry
(Qiagen, CA, USA) resin equilibrated with disruption bu¡er. The
suspension was mixed gently for 1 h at 4‡C and, after centrifugation,
the resin was washed four times with 12 ml of wash bu¡er (50 mM
sodium phosphate pH 7.4, 300 mM NaCl, 20 mM imidazole, 1%
Tween-20, 10% glycerol and the same protease inhibitors indicated
before). Bound proteins were eluted with the same bu¡er containing
250 mM of imidazole. Fractions were subjected to a 10% SDS^PAGE
and the tagged protein was detected by Western blot analysis using
the His probe H3 (SC-8036, Santa Cruz, CA, USA) followed by the
phosphatase alkaline reaction. Fraction containing 6UHis-Bdf1p was
dialysed against bu¡er P (15 mM sodium phosphate pH 7.6, 150 mM
NaCl, 20 mM imidazole, 0.05% Tween-20) and concentrated by ultra-
¢ltration using a 30 kDa cut o¡ ¢lter device (Filtron Technology
Corporation, MA, USA) before used to in vitro protein interaction
assays.
2.3. Pull-down assays between Bdf1p and core histones
Chicken erythrocyte core histones and individual H3 and H4 his-
tones were obtained as described elsewhere [23]. An aliquot of 15 Wl of
the recombinant 6UHis-Bdf1p preparation was mixed with 20 Wg of
core histones or with 5 Wg of each of the isolated H3 and H4 histones
in a total volume of 50 Wl. Samples were incubated during 1^2 h with
gently agitation at room temperature. After adding 16 Wl of 50%
slurry Ni2-NTA agarose resin equilibrated in bu¡er P, the mixtures
were incubated for 1^2 h more. The resin was washed ¢ve times with
500 Wl of bu¡er P, resuspended in sample solution and subjected to
SDS^PAGE analysis. AUT^PAGE [23] was used to assess the acety-
lation degree of retained histones. In this case, the pull-down assay
was scaled up four times. Coomassie blue staining was used in both
types of electrophoresis to detect proteins.
2.4. Search of HAT activity associated to Bdf1p
Liquid HAT activity assays were performed with the recombinant
6UHis-Bdf1p and using chicken erythrocyte free histones and
[1-14C]acetyl-CoA (Amersham Pharmacia Biotech, 52 mCi/mmol) as
substrates, exactly as described previously [24].
Preparation of cell extracts from yeast MCY3015 wild-type and
MCY3017bdf1 mutant strains (kindly supplied by M. Carlson), chro-
matographic fractionation of enzymes and analysis of HAT activities
were carried out as described [24].
3. Results
3.1. Identi¢cation of potential histone H4-interacting proteins
To explore interactions between histones and proteins that
could participate in the transcriptional process, a yeast two-
hybrid screen was performed to identify proteins able to in-
teract with a Gal4(DBD)-H4 fusion protein, including amino
acids 1^59 of this histone. This H4 fragment contains the
acetylatable Lys 5, 8, 12 and 16. Using the genomic library
Y2HL-C3 fused to Gal4(AD), 5U106 transformants were
Fig. 1. Interaction of Gal4(DBD)-H4(1^59) with Gal4(AD)-
Bdf1(304^571) fusion proteins in the two-hybrid system. (A) List of
the plasmids used for double transformation. (B) Growth of the
double transformants on SC-Trp,Leu,His,Ade medium. (C) L-Galac-
tosidase activity of the indicated transformants; data represent the
average values þ S.E.M. from at least three experiments in liquid
SC-Trp,Leu medium.
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screened. Of these transformants, 25 grew on doubly selective
media, and from these positive clones, only two exhibited
signi¢cantly elevated levels of L-galactosidase activity
(162 þ 33 U/mg of protein) relative to the reporter strain
(30 þ 5 U/mg of protein). Plasmid puri¢cation and sequence
analysis revealed that both clones (obtained from di¡erent
screens) corresponded to the same fusion fragment (nucleo-
tides 914^1715) of the yeast gene bromodomain factor 1
(BDF1 ; YLR399C locus). Con¢rmation of the H4^Bdf1p in-
teraction was done by reconstruction. Yeast strain PJ69-4A
was transformed with the bait and the prey plasmids (de-
scribed in Fig. 1A), and plated on selective media. Cell growth
was only observed in the case where both fusion proteins were
expressed (Fig. 1B). Moreover, these transformants exhibit a
3^5-fold increase in L-galactosidase activity relative to the
control strains (Fig. 1C). Fig. 2 illustrates the position of
the isolated Bdf1p fragment (amino acids 304^571) with re-
spect to the sequence of the entire Bdf1p [25]. This fragment
contains the complete sequence of one of the two bromodo-
mains, the bromodomain 2 (amino acids 335^413) and ap-
proximately one-third of the extra terminal domain.
3.2. Interaction between Bdf1p and di¡erent fragments of
histone H4
In order to determine whether the isolated Bdf1p fragment
(amino acids 304^571) could interact with N-terminal H4
fragments of various lengths, we assayed two-hybrid interac-
tions with gene fusions expressing the regions indicated in
Table 1. Yeast cells, coexpressing Gal4(AD)-Bdf1(304^571)
and the various Gal4(DBD)-histone H4 fusions, were incu-
bated on selective plates. Activation of reporter genes was
not observed when Gal4(AD)-Bdf1 was coexpressed with
any of the Gal4(DBD)-H4 fusions shorter than the ¢rst 59
amino acids. Interestingly, the construct Gal4(DBD)-H4(1^
59) appears to activate transcription better than full-length
H4 (102 amino acids), as colonies grew up within 2 days as
opposed to 4 days in the case of the Gal4(DBD)-H4(1^102)
construct. These results agree with those obtained when we
measured the L-galactosidase activity of the respective trans-
formants (results not shown). Together, these results suggest
that in the context of the two-hybrid assay, the interaction
between Bdf1p and histone H4 requires more than the ¢rst 37
amino acids of H4, and that this interaction is stronger in the
case of the 1^59 N-terminal fragment than with the full-length
histone.
3.3. Bdf1p interacts physically with histone H4 and histone H3
in vitro
To con¢rm the interaction between Bdf1p and histone H4
we performed in vitro pull-down assays using core and the
recombinant full-length 6UHis-tagged Bdf1p. We observed
that histones H4 and H3 were retained by Bdf1p (Fig. 3A),
while H2A and H2B were recovered in the non-retained frac-
tion. The retention of H3 and H4 was not observed in the case
where core histones were incubated with Ni2-NTA agarose
resin alone (Fig. 3A), therefore it is a result of Bdf1p inter-
action. Further demonstration of the interaction speci¢city
was provided by replacement of core histones with cyto-
chrome c in the pull-down assay. Cytochrome c is similar to
histones in that it is a small, basic protein. The data obtained
indicate that there was no interaction between Bdf1p and
cytochrome c (Fig. 3A). To eliminate the possibility that the
interaction between H3 and Bdf1p was due to the fact that H3
and H4 can dimerise, pull-down assays were carried out on
H3 and H4 individually. In these experiments, H3 and H4
were recovered in the respective retained fractions (Fig. 3A).
Note that although our preparation of Bdf1p gives several
Fig. 2. Structure of the Bdf1p. The fragment isolated (amino acids
304^571) by two-hybrid screen using the N-terminal (amino acids 1^
59) portion of H4 is represented below.
Table 1
Relative growth on SC-Trp,Leu,His,Ade medium of transformants
obtained on two-hybrid assays using the plasmid containing the
fragment corresponding to amino acids 304^571 of Bdf1p fused to
the AD of Gal4p and the di¡erent plasmids (pGBD-H4) that con-
tain histone H4 fragments fused to the DBD of Gal4p
Transformant Growth on plates
pGBD-H4(1^22)/pGAD-Bdf1 3
pGBD-H4(1^37)/pGAD-Bdf1 3
pGBD-H4(1^59)/pGAD-Bdf1 ++++
pGBD-H4(1^102)/pGAD-Bdf1 ++
Fig. 3. In vitro interaction between recombinant Bdf1p and his-
tones. Chicken core histones or individually histones H3 and H4
were mixed with recombinant 6UHis-Bdf1p and, after incubation,
pulled-down by adding Ni2-NTA agarose resin. As controls, core
histones in the absence of 6UHis-Bdf1p, and cytochrome c were in-
cubated and processed identically. Input (I), retained (R) and non-
retained (NR) fractions were analysed by SDS^ (A) or AUT^ (B)
PAGE. Lane M corresponds to the markers of which molecular
weights are indicated on the left of A. Arrow shows the position of
recombinant full-length 6UHis-Bdf1p. Ac denotes the acetylation
degree of histones H3 and H4 resolved by AUT^PAGE.
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bands in the SDS^PAGE gel, reported data [25] and Western
analysis (results not shown) con¢rm that the band migrating
as a 94 kDa protein corresponds to the full-length Bdf1p.
It has been suggested that bromodomains bind to N-termi-
nal tails of histones with a strong preference for the acetylated
forms (reviewed in [26]). In particular, a recent study suggests
that Gcn5p bromodomain may discriminate between di¡erent
acetylated lysine residues depending on the context in which
they are displayed [27]. In order to examine the possible pref-
erence of Bdf1p for a particular acetylation state of histones
H3 and H4, pull-down fractions were analysed by AUT^
PAGE. As shown in Fig. 3B, we found that Bdf1p interacts
to the same extent with non-acetylated H3 and H4 as with
di¡erent acetylated isoforms. Thus, we do not detect prefer-
ential binding of Bdf1p to the acetylated forms of H3 or H4.
3.4. Does Bdf1p have HAT activity?
The fact that other bromodomain proteins have been re-
ported to exhibit HAT activity [10,11,28] suggests that Bdf1p
may also be able to acetylate histones, an idea that was fur-
ther supported by its speci¢c interaction with the N-terminal
portions of H3 and H4. We employed two di¡erent experi-
mental approaches to investigate this possibility. First, we
assayed recombinant Bdf1p for HAT activity using core his-
tones as substrate. HAT activity was not detected in these
assays. Second, using yeast cell extracts from wild-type and
bdf1 mutant strains, the HAT activity pro¢les were compared
following the strategy previously described in our laboratory
[24]. There were no di¡erences detected between the HAT
pro¢les of these two strains (results not shown). In conclusion,
in our experimental conditions, we are not able to detect HAT
activity associated with Bdf1p.
4. Discussion
In recent years, modi¢cation of chromatin structure has
been revealed to be an important step in the activation of
gene expression. A relevant feature of certain proteins that
modify or remodellate chromatin structure is to contain a
conserved sequence called bromodomain, consisting of 60^
110 amino acids [29,30]. In fact, many of the known HAT
enzymes associated with transcriptional coactivators contain
bromodomains. Examples of such proteins are yeast Gcn5p
and P/CAF, a large complex in human cells with HAT activity
[29,30]. Surprisingly, human TafII250 is also a HAT-contain-
ing bromodomain, while its yeast homologue (Taf145p) has
HAT activity, but lacks the bromodomain [11]. This con-
served module is also present in the ATPase subunit of several
chromatin remodelling complexes such as RSC and SWI/SNF
[29,30]. All these data suggest that bromodomain-containing
proteins could interact in vivo with components of chromatin,
like histones. Consistently with this idea, there are several
studies showing that bromodomain-containing proteins, or
the bromodomain fragment alone, can interact in vitro with
the N-terminal region of histones H3 or H4 [8,9,27,31]. In this
report, we show for the ¢rst time the existence of an in vivo
interaction between a bromodomain-containing fragment of
yeast Bdf1p and the N-terminal region of histone H4.
Yeast Bdf1p was originally identi¢ed as a transcriptional
factor involved in the expression of several genes including
snRNAs [32]. However, an additional study postulates that
Bdf1p is a component of chromatin required for sporulation
[25]. These authors explain the implication of Bdf1p in gene
expression as a result of alterations in chromatin structure.
Finally, using a yeast two-hybrid screen, it has recently been
shown that Bdf1p interacts with Taf67p, a TBP-associated
factor of yeast TFIID [33]. The existence of an in vivo inter-
action between Bdf1p and the N-terminal region of histone
H4 is reinforced by all of these data. However, while it has
been reported that other bromodomain proteins can interact
with H4-derived peptides comprising of 1^12 [9], 1^34 [31], 1^
36 [8] and 15^29 [27] in vitro, we have not been able to dem-
onstrate any interaction between our Bdf1p fragment and H4
fragments smaller than the ¢rst 59 amino acids in vivo. This
may simply be a consequence of di¡erent speci¢c a⁄nities,
depending on the bromodomain sequence, or it may alterna-
tively demonstrate that the in vivo assay requires a longer N-
terminal fragment for detection. On the other hand, the weak-
er interaction shown by the full-length histone H4 with respect
to the portion 1^59 on the two-hybrid assays could be a con-
sequence of folding di¡erences between both fusion proteins.
On the other hand, the weaker interaction observed with the
full-length histone H4 compared to the portion 1^59 in the
two-hybrid assay could be due to folding di¡erences.
Another variable to consider is the potential role of varying
acetylation degree at the histone N-termini as a way of regu-
lating their interactions with bromodomain proteins. It has
been reported that P/CAF bromodomain [9], TafII250 dibro-
modomain [8] and Gcn5p bromodomain [27] preferentially
bind the N-terminal peptides of H4 containing di¡erent ace-
tylated lysine residues. In the case of Gcn5p, the bromodo-
main association is speci¢c to histones H3 and H4, and can
occur in the absence of acetylation [31]. A more recent study
further demonstrated that the Gcn5 bromodomain can inter-
act preferentially with a peptide corresponding to residues 15^
29 of histone H4 acetylated at the lysine 16, but also shows
that there are additional contacts between the peptide and the
bromodomain at non-acetylated residues [27]. Thus, although
we were unable to detect any preferential interaction between
Bdf1p and acetylated forms of H3 and H4 (Fig. 3B), this does
not discard the possibility of a binding dependence on the
acetylation degree of histones. It has been proposed that bro-
modomains may participate in two discrete interactions with
histone tails : a lower a⁄nity interaction with the N-terminal
region of the protein and a higher a⁄nity interaction upon
recognition of a speci¢cally acetylated lysine residue [26]. Tak-
en all together, in vitro and in vivo results suggest that the
interaction between bromodomain proteins and histone H4 is
not limited to the acetylatable 1^16 amino acids region, but
that it can be exercised in a larger domain. This interaction
could also be intensi¢ed by the acetylation of certain lysine
residues.
Finally, unlike the reports of HAT activity for other bro-
modomain proteins such as yeast Gcn5p [10], human P/CAF
[28] or human TafII250 [11], we have been unable to detect
any HAT activity for recombinant Bdf1p. In this sense, based
upon structural and functional comparisons, it has been pro-
posed that Bdf1p corresponds to the carboxy-terminal region
of higher eukaryotic TafII250 [33]. This protein exhibits ace-
tyltransferase activity, has two bromodomains and an associ-
ated kinase activity, whereas its yeast homologue (Taf145p)
has only the acetyltransferase activity. There are two bromo-
domains and kinase activity present in Bdf1p. Yeast Taf145p
and Bdf1p combined could thus represent the actual homo-
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logue of human TafII250 [33]. The fact that Bdf1p lacks HAT
activity is in accordance with this hypothesis. Since Bdf1p
interacts with Taf67p [33] and, as described here, with the
N-terminal region of histone H4, this bromodomain protein
could participate in the recruitment of the transcription fac-
tors needed to gene activation if acting in partnership with
yeast Taf145p HAT.
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